Commitments and Contingencies (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 20, 2024 |
Jan. 09, 2023 |
Jan. 06, 2023 |
Jan. 06, 2023 |
Jan. 04, 2023 |
Dec. 30, 2022 |
Mar. 31, 2024 |
Sep. 30, 2024 |
Dec. 31, 2023 |
Mar. 31, 2025 |
Dec. 31, 2024 |
|
Common Stock [Member] | |||||||||||
Subsidiary, Sale of Stock [Line Items] | |||||||||||
Issue of ordinary shares, shares | 1 | ||||||||||
Alphatime Acquisition Corp [Member] | |||||||||||
Subsidiary, Sale of Stock [Line Items] | |||||||||||
Issue of ordinary shares, shares | 3,403,976 | 5,800 | |||||||||
Payments for underwriting expense | $ 1,500,000 | ||||||||||
Number of stock exercisable, shares | 115,500 | ||||||||||
Share issued price per share | $ 10.18 | $ 2.00 | |||||||||
Option description | The option and the 58,000 Units, as well as the 58,000 ordinary shares, the warrants to purchase 58,000 ordinary shares that may be issued upon exercise of the option and the rights to purchase 5,800 ordinary shares upon the completion of an initial business combination, have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the commencement of sales in our IPO pursuant to Rule 5110(e)(1) of FINRA’s Rules, during which time the option may not be sold, transferred, assigned, pledged or hypothecated, or be subject of any hedging, short sale, derivative or put or call transaction that would result in the economic disposition of the securities, except as permitted under FINRA Rule 5110(e)(2). The Company determined fair value of the Unit Purchase Option issued to the underwriters and recorded an amount to additional paid-in capital, net of purchased cost, in the balance sheets on the day of the IPO which is the grant date. | ||||||||||
Number of units option exercised, shares | $ 58,000 | ||||||||||
Alphatime Acquisition Corp [Member] | H C Y C Holding Company [Member] | |||||||||||
Subsidiary, Sale of Stock [Line Items] | |||||||||||
Other Liabilities, Current | $ 141,811 | $ 0 | |||||||||
Alphatime Acquisition Corp [Member] | Common Stock [Member] | |||||||||||
Subsidiary, Sale of Stock [Line Items] | |||||||||||
Issue of ordinary shares, shares | 58,000 | 6,000,000 | |||||||||
Over-Allotment Option [Member] | Alphatime Acquisition Corp [Member] | |||||||||||
Subsidiary, Sale of Stock [Line Items] | |||||||||||
Issue of ordinary shares, shares | 900,000 | 900,000 | 900,000 | 900,000 | |||||||
Sale of price per share | $ 10.00 | $ 10.00 | $ 10.00 | ||||||||
Payments for underwriting expense | $ 112,500 | ||||||||||
Share price | $ 0.35 | ||||||||||
Deferred underwriting commission | $ 2,415,000 | ||||||||||
Number of stock exercisable, shares | 900,000 | ||||||||||
Unit Purchase Option [Member] | Alphatime Acquisition Corp [Member] | |||||||||||
Subsidiary, Sale of Stock [Line Items] | |||||||||||
Issue of ordinary shares, shares | 5,800 | ||||||||||
Sale of price per share | $ 100 | ||||||||||
Number of stock exercisable, shares | 58,000 | ||||||||||
Share issued price per share | $ 11.50 | ||||||||||
Percentage of market value | 115.00% | ||||||||||
Option description | The option and the | ||||||||||
Number of units option exercised, shares | $ 58,000 | ||||||||||
Unit Purchase Option [Member] | Alphatime Acquisition Corp [Member] | Common Stock [Member] | |||||||||||
Subsidiary, Sale of Stock [Line Items] | |||||||||||
Issue of ordinary shares, shares | 58,000 |